Sponsor

Media Partner

 

 

Be the first to know

Join CMC email list to receive latest event news and updates.

This form does not yet contain any fields.

    OTC and Listed Derivatives in the wake of Dodd-Frank

    April 27, 2011, New York City

    This event takes a deep dive at Regulatory and Business issues impacting the Derivatives space, both OTC and Listed. Dodd-Frank regulations and their impact on Central Clearing of OTC Derivatives will be explored as well as implications for market participants. For Listed Derivatives, an evolving Market Structure will be examined, and whether new rules promote competition and enhance liquidity or merely add to costs, complexity and fragmentation without mitigating risk.                                   

    Agenda     

    1:00 - 1:20


    Registration

    1:20 - 1:25


    Opening Remarks


     

    OTC DERIVATIVES PERSPECTIVE

    1:25 - 2:05

     

    Panel 1: Update on Central Counterparty Clearing

    - How to increase availability of CCPs and products cleared
    - Ensuring interoperability among vendors and CCPs
    - Maintaining robust risk management

    SEAN OWENS, Director, Woodbine Associates (Moderator)

    CORRY BAZLEY, Director of Sales and Marketing, ICE Trust

    MATTHEW GUADAGNO, Director, International Derivatives Clearing Group

    AMY MCCORMICK, Director, Market Risk Management, CME Group

    2:05 - 2:45

     

    Panel 2: Business Implications of Dodd Frank on the Buy and Sell Side

    - Opportunity cost of posting collateral for Asset Managers
    - Systematic Risk, Transparency & Product Liquidity
    - Are customized bilateral solutions obsolete?

    VINOD JAIN, Managing Consultant, Headstrong (Moderator)

    MAYIZ HABBAL, Senior Vice President, Securities & Investments Group, Celent

    ANDREW MCGUIRE, Senior Vice President, LCH Clearnet

    BIKRAM SINGH, Director, Business Head of OTC Derivatives Services, Citi

    2:45 - 3:10

     

    Break


     

    LISTED DERIVATIVES PERSPECTIVE

    3:10 - 3:50

     

    Panel 3: Impact of regulatory changes on Business Models

    - Competition among exchanges
    - Order flows, rule changes and price of options execution
    - Market Access Rule and banning flash orders

    BOB FITZSIMMONS, Managing Director, Head of Derivatives Business, ITG  (Moderator)

    ANDY BRENNER, President, Electronic Brokerage Systems

    SHELLY BROWN, Senior VP, Strategic Planning and Operations, Miami International Holdings

    STEVE CRUTCHFIELD, CEO, NYSE Amex Options

    MICHAEL WEST, Vice President, NASDAQ OMX Options

    3:50 - 4:30

     

    Panel 4: High Frequency Traders vs Market Makers - How is Market Structure changing

    - Quoting obligations
    - Spread differential and trading volume
    - Electronic Trading of Index Options

    DAVID MORTIMER, Managing Director, Equity Options, Pipeline

    ANDY NYBO, Principal, Head of Derivatives , TABB Group (Moderator)

    TODD RAARUP, Managing Director, Citigroup Global Equities

    ALICIA REILLY, Head of Options Trading, Bloomberg Tradebook Derivatives

    4:30 - 5:00

     

    Keynote

    IRENE MOYSEYENKO, Special Counsel, Willkie Farr & Gallagher LLP

    5:00 - 6:00

     

    Cocktails

    Registration    
    Fee  

    This event is closed.

    Location    
    Address  

    Bayard's

    One Hanover Square · New York, NY 10004

    Click here for directions.